Malignant hyperthermia – an actual overview
Authors:
E. Kurča 1; B. Sániová 2; M. Drobný 1; P. Kučera 3
Authors‘ workplace:
Neurologická klinika JLF UK a FN Martin, prednosta prof. MUDr. Michal Drobný, DrSc. 2 ARK JLF UK a FN Martin, prednosta MUDr. Beata Sániová, CSc. 3 1. neurologická klinika LF UK a FN Bratislava, prednosta prof. MUDr. Pavol Traubner, CSc.
1
Published in:
Anest. intenziv. Med., , 1998, č. 6, s. 221-225
Category:
Overview
Malignant hyperthermia (MH) is a hereditar disorder of skeletal muscle characterised by a paroxysmal hypermetabolic state of muscle fibers. MH is triggered by some drugs usually during general anesthesia. MH may lead to death if no accurate therapy is applied immediately. An overview of MH epidemiology, pathogenesis, clinics, therapy and genetics is presented with attention to counselling and situation in Slovakia.
Key words:
malignant hyperthermia – masseter rigidity – calcium channels – genetics
Labels
Anaesthesiology, Resuscitation and Inten Intensive Care MedicineArticle was published in
Anaesthesiology and Intensive Care Medicine
1998 Issue 6
Most read in this issue
- Malignant hyperthermia – an actual overview
- Prognostic value of pEtCO2 monitoring during CPR in out-of-hospital setting
- Intracranial hypertension – treatment
- First experience with the use of COPA during anesthesia – a comparison with laryngeal mask airway